StemCell Therapy

NIH is institutinga number ofchanges tohow it categorizes clinical trial research.Many ELSI studiesthat previously were not considered clinical trials will now be categorized as such and will be subject to new application, review and reporting requirements.Please visit theClinical Trials definition websitefor guidance indetermininghow your study will be categorized. If you have any questions or concerns, please contact ourELSIprogram directors

ELSI applications that do not involve a clinical trial can still be submitted under the ELSI R01, R21 and R03 program announcements listed below.

ELSI applicationsthat are determined to involve a clinical trial cannot be submitted under these announcements and must now besubmitted under either the NIHParent R01--Clinical Trial Required(PA-18-345)or the NIHParent R21--Clinical Trial Required (PA-18-344)program announcements.When submitting these applications, researchers shoulduse thePHS Assignment Request Formtorequest thatNHGRI (and any other relevant Institutes or Centers) be assigned the grant, andtorequest study section review assignment to theContinuous Special Emphasis Panel on Societal and Ethical Issues in Research Study Section(ZRG1 SEIR).

The NHGRI, along with several other National Institutes of Health (NIH) institutes, has released revised general program announcements to solicit research projects that anticipate, analyze, and address the ethical, legal, and social implications of the discovery of new genetic technologies and the availability and use of genetic information resulting from human genetics and genomic research.

The NHGRI ELSI Program accepts Conference Grant (R13) applications. For specific instructions for preparing a conference grant application, see:

The ELSI program participates in a number of training and career development funding opportunities.

The Fogarty International Center'sinternational bioethics training programs[fic.nih.gov] support education and research training to develop ethics expertise in low- and middle-income countries (LMICs). The programs complement other global health research and research training programs in the mission areas of NIH Institutes and Centers.

PA-16-288:Research Supplements to Promote Diversity in Health-Related Research (Admin Supp)Expiration Date: September 30, 2019

PA-16-289:Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp)Expiration Date: September 30, 2019

Read more:
Ethical, Legal and Social Implications Research Program ...

This entry was posted on April 30, 2019 at 3:57 pm and is filed under Legal Issues Genetic Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |